TransMedics Group, Inc.
Price Chart
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $2.72B |
| Revenue | $636M |
| Net Income | $172M |
| Total Assets | $1.43B |
| Net Assets | $494M |
| Employees | 898 |
| Value | |
| P/E | 15.84x |
| P/B | 5.51x |
| P/S | 4.28x |
| EV/EBITDA | 22.42x |
| FCF Yield | 5.56% |
| Profitability | |
| ROE | 34.80% |
| ROA | 11.98% |
| Op. Margin | 14.85% |
| Revenue Growth | 21.18% |
| Earnings Growth | -71.52% |
| Financial Health | |
| Debt Ratio | 190.45% |
| Total Debt | $819M |
| FCF | $151M |
| Cash | $462M |
| Current Ratio | 6.74x |
| Net Debt/EBITDA | 2.60x |
| Performance | |
| 1Y Return | -36.46% |
| 1M Return | 19.14% |
| From 52W High | -49.49% |
| 1Y MDD | -58.76% |
| Trading | |
| Volume | 1,719,376 shares |
| Trading Value | $134M |
| Per Share | |
| EPS | $5.56 |
| BPS | $13.83 |
Company Info
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.